These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 4983105)
21. [Effect of dioxyphenylalanine (L-DOPA) on extrapyramidal motoric hyperkineses after prolonged neuroleptic therapy]. Hippius H; Logemann G Arzneimittelforschung; 1970 Jul; 20(7):894-6. PubMed ID: 5536051 [No Abstract] [Full Text] [Related]
22. [The semiology of motor function disorders during treatment with neuroleptic drugs]. Fleĭs EP Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(12):1798-804. PubMed ID: 5511943 [No Abstract] [Full Text] [Related]
23. Drug induced parkinsonism. A re-evaluation. Fann WE; Lake CR; Richman BW Dis Nerv Syst; 1975 Feb; 36(2):91-3. PubMed ID: 1116421 [No Abstract] [Full Text] [Related]
24. [Correlation between antipsychotic and extrapyramidal properties of neuroleptics]. Filotto J; Bordeleau JM; Tétreault L Union Med Can; 1969 Apr; 98(4):562-6. PubMed ID: 5355787 [No Abstract] [Full Text] [Related]
27. [Extrapyramidal accidents in outpatient therapy]. Rouleau Y Laval Med; 1970 Sep; 41(7):906-8. PubMed ID: 5509488 [No Abstract] [Full Text] [Related]
28. Long-acting, antipsychotic agents and extrapyramidal side effects. Simpson GM Dis Nerv Syst; 1970 Sep; 31():Suppl:12-4. PubMed ID: 5476354 [No Abstract] [Full Text] [Related]
29. [Individual predisposition for unusual extrapyramidal side effects with neuroleptic agents]. Lingjaerde O Tidsskr Nor Laegeforen; 1971 May; 91(13):977-9. PubMed ID: 5576970 [No Abstract] [Full Text] [Related]
30. [A chronic extrapyramidal syndrome as a complication of neuroleptic therapy]. Gurovich IIa; Fleĭs EP Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(12):1862-8. PubMed ID: 5375563 [No Abstract] [Full Text] [Related]
31. [Extrapyramidal symptoms during the use of neuroleptics]. Ditfurth HV Nervenarzt; 1967 Apr; 38(4):151-5. PubMed ID: 4382350 [No Abstract] [Full Text] [Related]
32. [Extrapyramidal syndrome and spondyloarthritis ankylopoietica in a schizophrenic patient]. Lipiński B Psychiatr Pol; 1970; 4(2):211-4. PubMed ID: 5427765 [No Abstract] [Full Text] [Related]
33. [Neurologic and psychic complications in treatment with neuroleptics]. Gerlach J Ugeskr Laeger; 1976 Jun; 138(27):1650-3. PubMed ID: 951778 [No Abstract] [Full Text] [Related]
38. Lack of indication for use of antiparkinson medication. A follow-up study. Pecknold JC; Ananth JV; Ban TA; Lehmann HE Dis Nerv Syst; 1971 Aug; 32(8):538-41. PubMed ID: 5094160 [No Abstract] [Full Text] [Related]
39. [Long-acting antiparkinson agents. I. Pilot study on benzetimide (342 cases)]. Korn M; Pinchard A; Breulet M; Goffioul F; Bobon J Acta Psychiatr Belg; 1971 Mar; 71(2):65-75. PubMed ID: 5560276 [No Abstract] [Full Text] [Related]
40. [Transitory exacerbations arising during the course of neuroleptic therapy]. Gurovich IIa Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(6):919-25. PubMed ID: 5471621 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]